These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16414136)

  • 21. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
    Dehing-Oberije C; Yu S; De Ruysscher D; Meersschout S; Van Beek K; Lievens Y; Van Meerbeeck J; De Neve W; Rao B; van der Weide H; Lambin P
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):355-62. PubMed ID: 19095367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
    Tucker SL; Liu HH; Wang S; Wei X; Liao Z; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):754-61. PubMed ID: 16965865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer.
    Fujita S; Katakami N; Takahashi Y; Hirokawa K; Ikeda A; Tabata C; Mio T; Mishima M
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):896-901. PubMed ID: 16675259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
    van den Hout WB; Kramer GW; Noordijk EM; Leer JW
    J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques.
    Johansen S; Cozzi L; Olsen DR
    Acta Oncol; 2009; 48(4):495-503. PubMed ID: 19169915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
    van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.
    Schild SE; McGinnis WL; Graham D; Hillman S; Fitch TR; Northfelt D; Garces YI; Shahidi H; Tschetter LK; Schaefer PL; Adjei A; Jett J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1106-11. PubMed ID: 16730134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involved-field radiation therapy for inoperable non small-cell lung cancer.
    Rosenzweig KE; Sura S; Jackson A; Yorke E
    J Clin Oncol; 2007 Dec; 25(35):5557-61. PubMed ID: 17984185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment.
    Schwarz M; Van der Geer J; Van Herk M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1260-9. PubMed ID: 16798418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary function in long-term survivors of testicular cancer.
    Haugnes HS; Aass N; Fosså SD; Dahl O; Brydøy M; Aasebø U; Wilsgaard T; Bremnes RM
    J Clin Oncol; 2009 Jun; 27(17):2779-86. PubMed ID: 19414680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome.
    Pemberton LS; Din OS; Fisher PM; Hatton MQ
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
    Niibe Y; Hayakawa K; Masuda N; Yoshimura H
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors.
    El Naqa I; Bradley J; Blanco AI; Lindsay PE; Vicic M; Hope A; Deasy JO
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1275-86. PubMed ID: 16504765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study.
    Petit SF; Aerts HJ; van Loon JG; Offermann C; Houben R; Winkens B; Ollers MC; Lambin P; De Ruysscher D; Dekker AL
    Radiother Oncol; 2009 Jun; 91(3):393-8. PubMed ID: 19328570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
    St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
    Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.